With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...
We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...
Numerous private clinics claim to offer miraculous cures for hard-to-treat medical conditions, even though their treatments ...
When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...
A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...
By the time she was treated, she was almost completely paralyzed, Monje said. The treatment worked so well that her tumor ...
The origin of many diseases such as Alzheimer's or Parkinson's can be found at the molecular level in our body, in other ...
A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for ...
Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback